Adrian Gottschalk
Chief Executive Officer at Foghorn Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Foghorn Therapeutics Inc., 3 years.
Foghorn Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Foghorn Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2023 | Foghorn Therapeutics Inc. | Gift | −63,000 | — | — |
| Aug 17, 2023 | Foghorn Therapeutics Inc. | Gift | +63,000 | — | — |
| May 26, 2023 | Foghorn Therapeutics Inc. | Gift | −300,000 | — | — |
| May 26, 2023 | Foghorn Therapeutics Inc. | Gift | +300,000 | — | — |
| Feb 17, 2023 | Foghorn Therapeutics Inc. | Gift | −4,371 | — | — |
| Feb 17, 2023 | Foghorn Therapeutics Inc. | Gift | +4,371 | — | — |
| Feb 17, 2023 | Foghorn Therapeutics Inc. | Other | −184,939 | — | — |
| Feb 17, 2023 | Foghorn Therapeutics Inc. | Other | +184,939 | — | — |
| Oct 25, 2022 | Foghorn Therapeutics Inc. | Other | +4,371 | — | — |
| Oct 25, 2022 | Foghorn Therapeutics Inc. | Other | −4,371 | — | — |
| Feb 10, 2022 | Foghorn Therapeutics Inc. | Gift | −123,479 | — | — |
| Feb 10, 2022 | Foghorn Therapeutics Inc. | Gift | +123,479 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.